Sign in
Explore the registryTrack Oleclumab's trials

Oleclumab (MEDI9447) Epidermal Growth Factor Receptor Mutant (EGFRm) Non-small Cell Lung Cancer (NSCLC) Novel Combination Study

OleclumabOngoingActive not recruitingPhase 1Open NCT03381274 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…